NDC product
Fluzone High-Dose Quadrivalent Northern Hemisphere
NDC 49281-226 · Sanofi Pasteur Inc.
Key facts
| Product NDC | 49281-226 |
|---|---|
| Proprietary name | Fluzone High-Dose Quadrivalent Northern Hemisphere |
| Labeler | Sanofi Pasteur Inc. |
| Marketing category | BLA |
| Application number | BLA103914 |
| Marketing start | Jul 1, 2025 |
| Marketing end | Jun 30, 2026 |
| Listing certified through | Jun 30, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: